Marshall Wace’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $113M | Sell |
533,972
-417,287
| -44% | -$89.9M | 0.11% | 147 |
|
|
2025
Q4 | $195M | Buy |
951,259
+884,648
| +1,328% | +$166M | 0.18% | 86 |
|
|
2025
Q3 | $10.5M | Sell |
66,611
-1,864,356
| -97% | -$288M | 0.01% | 908 |
|
|
2025
Q2 | $324M | Buy |
1,930,967
+309,335
| +19% | +$45.9M | 0.37% | 37 |
|
|
2025
Q1 | $223M | Sell |
1,621,632
-1,530,104
| -49% | -$195M | 0.28% | 53 |
|
|
2024
Q4 | $373M | Buy |
3,151,736
+1,913,892
| +155% | +$223M | 0.45% | 23 |
|
|
2024
Q3 | $137M | Buy |
1,237,844
+1,217,713
| +6,049% | +$127M | 0.17% | 98 |
|
|
2024
Q2 | $1.98M | Buy |
+20,131
| New | +$2.05M | ﹤0.01% | 1374 |
|
|
2024
Q1 | – | Sell |
-38,422
| Closed | -$3.87M | – | 2458 |
|
|
2023
Q4 | $3.87M | Sell |
38,422
-657,603
| -94% | -$65.2M | 0.01% | 1000 |
|
|
2023
Q3 | $60.4M | Sell |
696,025
-669,349
| -49% | -$60.5M | 0.12% | 165 |
|
|
2023
Q2 | $129M | Buy |
1,365,374
+1,262,881
| +1,232% | +$107M | 0.25% | 75 |
|
|
2023
Q1 | $7.74M | Sell |
102,493
-304,084
| -75% | -$22.9M | 0.02% | 806 |
|
|
2022
Q4 | $31.3M | Sell |
406,577
-853,063
| -68% | -$64.8M | 0.07% | 318 |
|
|
2022
Q3 | $84M | Buy |
1,259,640
+1,240,180
| +6,373% | +$78.6M | 0.18% | 107 |
|
|
2022
Q2 | $1.02M | Buy |
+19,460
| New | +$1.11M | ﹤0.01% | 2426 |
|
|
2022
Q1 | – | Sell |
-13,990
| Closed | -$721K | – | 3394 |
|
|
2021
Q4 | $721K | Sell |
13,990
-35,936
| -72% | -$1.76M | ﹤0.01% | 2625 |
|
|
2021
Q3 | $2.47M | Buy |
49,926
+34,803
| +230% | +$1.89M | 0.01% | 1396 |
|
|
2021
Q2 | $864K | Buy |
+15,123
| New | +$884K | ﹤0.01% | 1888 |
|
|
2021
Q1 | – | Sell |
-369,230
| Closed | -$19.8M | – | 2499 |
|
|
2020
Q4 | $19.8M | Buy |
369,230
+118,736
| +47% | +$6.16M | 0.11% | 195 |
|
|
2020
Q3 | $11.8M | Sell |
250,494
-101,706
| -29% | -$5.22M | 0.08% | 257 |
|
|
2020
Q2 | $18.4M | Buy |
352,200
+158,791
| +82% | +$8.19M | 0.13% | 164 |
|
|
2020
Q1 | $9.27M | Buy |
+193,409
| New | +$10M | 0.09% | 224 |
|
|
2019
Q4 | – | Sell |
-464,758
| Closed | -$21.9M | – | 1719 |
|
|
2019
Q3 | $21.9M | Buy |
464,758
+328,891
| +242% | +$15M | 0.17% | 133 |
|
|
2019
Q2 | $6.4M | Buy |
+135,867
| New | +$6.27M | 0.05% | 412 |
|
|
2019
Q1 | – | Sell |
-246,592
| Closed | -$11M | – | 1731 |
|
|
2018
Q4 | $11M | Buy |
+246,592
| New | +$12.9M | 0.11% | 222 |
|
|
2018
Q3 | – | Sell |
-28,274
| Closed | -$1.38M | – | 1142 |
|
|
2018
Q2 | $1.38M | Buy |
+28,274
| New | +$1.6M | 0.02% | 470 |
|
|
2017
Q4 | – | Sell |
-90,751
| Closed | -$6.08M | – | 408 |
|
|
2017
Q3 | $6.08M | Buy |
+90,751
| New | +$6.42M | 0.28% | 78 |
|
|
2016
Q2 | – | Sell |
-630,446
| Closed | -$51.7M | – | 996 |
|
|
2016
Q1 | $51.7M | Sell |
630,446
-50,407
| -7% | -$4.1M | 0.5% | 54 |
|
|
2015
Q4 | $60.8M | Sell |
680,853
-176,295
| -21% | -$15M | 0.57% | 38 |
|
|
2015
Q3 | $65.8M | Buy |
857,148
+294,530
| +52% | +$24.6M | 0.81% | 21 |
|
|
2015
Q2 | $47.1M | Buy |
562,618
+26,670
| +5% | +$2.35M | 0.61% | 36 |
|
|
2015
Q1 | $48.4M | Buy |
535,948
+100,597
| +23% | +$8.66M | 0.63% | 26 |
|
|
2014
Q4 | $35.1M | Buy |
435,351
+141,420
| +48% | +$11.2M | 0.46% | 52 |
|
|
2014
Q3 | $22M | Buy |
293,931
+90,121
| +44% | +$6.56M | 0.32% | 93 |
|
|
2014
Q2 | $14M | Buy |
+203,810
| New | +$13.9M | 0.21% | 140 |
|
Other funds holding CAH
VCM
VPM
Marshall Wace's CAH Position: Q1 2026 in Review
Marshall Wace reduced its Cardinal Health (CAH) stake by 44% in Q1 2026, selling an estimated $89.9M and leaving 533,972 shares worth $113M. The position accounts for 0.11% of the portfolio, ranked #147.
Marshall Wace first reported a position in CAH in Q2 2014 and has held it in 35 quarters since. The position peaked at $373M in Q4 2024. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Marshall Wace held 533,972 shares of Cardinal Health worth $113M as of Q1 2026.
- Marshall Wace sold 417,287 Cardinal Health shares in Q1 2026, an estimated $89.9M.
- Cardinal Health made up 0.11% of Marshall Wace's portfolio in Q1 2026, its #147 holding.
- Marshall Wace first reported a position in Cardinal Health in Q2 2014 and has held it in 35 quarters since.
- Marshall Wace's Cardinal Health position peaked at $373M in Q4 2024.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.